Healthcare / Medical Care FacilitiesJohannesburg
$1057.00
-13.00 (-1.21%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.6B · quality 80.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
43/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$15.1B
P/E
11.5x
↓EV/EBITDA
1480.9x
↑ROE
34.0%
↑Gross Margin
68.5%
↑Debt/Equity
0.35
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+6.9%
FCF CAGR
-1.7%
FCF margin
10.4%
FCF / Net income
0.68x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $25.10B · net income $3.86B · FCF $2.62B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $25.10B | $25.10B | $23.67B | $22.64B | $20.53B |
| Net Income | $3.86B | $3.86B | $4.83B | $264.0M | $1.53B |
| EBITDA | $1.04B | $1.04B | $3.80B | $3.62B | $3.53B |
| EPS | 2.63 | 2.63 | 3.29 | 0.18 | 1.05 |
| Gross Margin | 68.5% | 68.5% | 68.9% | 68.8% | 69.1% |
| Operating Margin | 9.0% | 9.0% | 9.3% | 10.0% | 10.0% |
| Net Margin | 15.4% | 15.4% | 20.4% | 1.2% | 7.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.35 | 0.35 | 0.35 | 0.65 | 0.73 |
| Current Ratio | 1.20 | 1.20 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.62B | $2.62B | $2.36B | $3.15B | $2.76B |
| Returns | |||||
| ROE | 34.0% | 34.0% | 38.5% | 1.3% | 8.2% |
| Valuation | |||||
| P/E | 11.49 | 11.49 | 517.34 | 11203.30 | 1648.62 |
| EV/EBITDA | 1480.89 | 1480.89 | 646.72 | 823.54 | 718.55 |
| P/B | 134.97 | 134.97 | 195.63 | 146.67 | 134.65 |
| Growth & Yield | |||||
| Revenue Growth | 6.0% | 6.0% | 4.6% | 10.3% | — |
| EPS Growth | -20.0% | -20.0% | 1706.6% | -82.7% | — |
| Dividend Yield | 5.4% | 5.4% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
229.2%
EPS terminal req.
$93.79
Spread vs growth
-249.2%
5Y implied EPS CAGR
112.3%
EPS terminal req.
$113.49
Spread vs growth
-132.3%
10Y implied EPS CAGR
52.8%
EPS terminal req.
$182.77
Spread vs growth
-72.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-20.7%
Start / end P/E
435.2x → 401.9x
EPS bridge
3.29 → 2.63
Residual
+1.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.